The Medical Center of Leiden University (LUMC) and Leiden University will participate in the development of a new antibiotic against tuberculosis. The European Union earmarked 18 million euros for international research.
Nine research groups are looking for new drugs for tuberculosis and two related bacteria. More than 1.5 million victims are required each year in the world.
Researcher Meindert Lamers from LUMC is pleased with the research. "This is indispensable. The treatment of tuberculosis is difficult and time-consuming and is increasingly inhibiting antibiotic resistance." The International Group also wants to develop more effective antibiotics that shorten the treatment of tuberculosis.
The research involves the University of Sorbonne in Paris, the University of Antwerp and the University of Vienna. It will take about six years, writes Omroep West.